Drug intelligence / Profile preview

passiflora incarnata + crataegus oxyacantha + salix alba

Development stage
Phase 3
Modality
Small Molecules
Administration
Oral
01

Overview

This drug is a **combination of herbal extracts**: *Passiflora incarnata* (commonly known as passionflower), *Crataegus oxyacantha* (hawthorn), and *Salix alba* (white willow). These plants have traditionally been used in European phytotherapy formulations for their distinct properties. - **Passiflora incarnata** is primarily known for its sedative, anxiolytic (anti-anxiety), and hypnotic activities. It is used to manage insomnia, anxiety, nervousness, neuralgia, menopausal symptoms, and sometimes for mild pain. Mechanistically, evidence suggests that it modulates gamma-aminobutyric acid (GABA) in the central nervous system, resulting in a calming effect[1][2][3][4][5]. - **Crataegus oxyacantha** (hawthorn) is a cardiotonic herb widely used for supporting cardiovascular health, improving cardiac function, reducing blood pressure, and treating mild heart failure. It contains flavonoids and oligomeric procyanidins that may exert antioxidant, vasodilatory, and antiarrhythmic effects. - **Salix alba** (white willow) is a traditional source of salicin, a precursor to salicylic acid, with analgesic (pain-relieving), anti-inflammatory, and antipyretic (fever-reducing) properties. It acts through inhibition of cyclooxygenase enzymes (COX), similar to nonsteroidal anti-inflammatory drugs (NSAIDs). This combination is typically marketed as a *natural calming, cardiotonic, and anti-inflammatory remedy*, often in dietary supplements or herbal preparations for relief of anxiety, mild pain, stress, sleep disorders, mild circulatory problems, or menopausal symptoms.

Brand names
Passiflora Crataegus
Other names
passionflower + hawthorn + white willow
02

Targets

PGHS-1 (Prostaglandin G/H Synthase 1)GABRR (GABA-A receptor subunit rho)

Beyond the preview

Go deeper on passiflora incarnata + crataegus oxyacantha + salix alba.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on passiflora incarnata + crataegus oxyacantha + salix alba.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call